These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22005546)

  • 21. Phosphatidykinosital 3-kinase and mammalian target of rapamycin pathway in non-small-cell lung cancer.
    Massarelli E; Papadimitrakopoulou VA
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S379-82. PubMed ID: 23160325
    [No Abstract]   [Full Text] [Related]  

  • 22. Update on HER1-3 in advanced non-small-cell lung cancer.
    Horn L; Lovly C
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S369-71. PubMed ID: 23160321
    [No Abstract]   [Full Text] [Related]  

  • 23. Phosphatidylinositol-3-kinase pathway.
    Reckamp KL
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S383-4. PubMed ID: 23160326
    [No Abstract]   [Full Text] [Related]  

  • 24. New advances in the second-line treatment of small cell lung cancer.
    Hurwitz JL; McCoy F; Scullin P; Fennell DA
    Oncologist; 2009 Oct; 14(10):986-94. PubMed ID: 19819917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Molecular targeted therapies in small-cell lung cancer].
    Levy A; Malouf GG; Besse B; Massard C; Soria JC
    Bull Cancer; 2010 May; 97(5):535-45. PubMed ID: 20093224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of limited disease small cell lung cancer.
    De Ruysscher D
    Eur J Cancer; 2009 Sep; 45 Suppl 1():425-6. PubMed ID: 19775657
    [No Abstract]   [Full Text] [Related]  

  • 27. Basket Trials: Just the End of the First Quarter.
    Stenzinger A; Weichert W; Lennerz JK; Klauschen F
    J Clin Oncol; 2015 Sep; 33(25):2823-4. PubMed ID: 26169614
    [No Abstract]   [Full Text] [Related]  

  • 28. EphB4: A promising target for upper aerodigestive malignancies.
    Salgia R; Kulkarni P; Gill PS
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):128-137. PubMed ID: 29369779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on new drugs in small cell lung cancer.
    Horn L; Castellanos EL; Johnson DH
    Expert Opin Investig Drugs; 2011 Apr; 20(4):441-5. PubMed ID: 21395484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting an autocrine loop in small-cell lung cancer: irrelevant target or ineffective drug?
    Glisson BS
    Clin Lung Cancer; 2010 Jul; 11(4):222. PubMed ID: 20630822
    [No Abstract]   [Full Text] [Related]  

  • 31. Tumor lysis syndrome in small cell lung cancer: a case report and review of the literature.
    Jallad B; Hamdi T; Latta S; Alhosaini MN; Kheir F; Iroegbu N
    Onkologie; 2011; 34(3):129-31. PubMed ID: 21358219
    [No Abstract]   [Full Text] [Related]  

  • 32. PARP inhibitors in lung cancer.
    Spigel DR
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S392-3. PubMed ID: 23160330
    [No Abstract]   [Full Text] [Related]  

  • 33. Extensive-stage small-cell lung cancer: evolution of systemic therapy and future directions.
    Allen J; Jahanzeb M
    Clin Lung Cancer; 2008 Sep; 9(5):262-70. PubMed ID: 18953759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reply to A. Stenzinger et al.
    Thomas A; Lopez-Chavez A; Giaccone G
    J Clin Oncol; 2015 Sep; 33(25):2824. PubMed ID: 26169619
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of surgery for small cell lung cancer.
    Friedberg J; Lotano VE
    Curr Probl Cancer; 2012; 36(3):117-30. PubMed ID: 22495058
    [No Abstract]   [Full Text] [Related]  

  • 36. Doubling down with inhibitors of Notch and Hedgehog signaling pathways.
    Weiss GJ
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S409-10. PubMed ID: 23160337
    [No Abstract]   [Full Text] [Related]  

  • 37. Medical treatment of small cell lung cancer: state of the art and new development.
    Sgambato A; Casaluce F; Maione P; Rossi A; Sacco PC; Panzone F; Ciardiello F; Gridelli C
    Expert Opin Pharmacother; 2013 Oct; 14(15):2019-31. PubMed ID: 23901936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted epidermal growth factor receptor therapy in malignant pleural mesothelioma: where do we stand?
    Agarwal V; Lind MJ; Cawkwell L
    Cancer Treat Rev; 2011 Nov; 37(7):533-42. PubMed ID: 21183281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting growth factors in lung cancer.
    Hodkinson PS; Mackinnon A; Sethi T
    Chest; 2008 May; 133(5):1209-16. PubMed ID: 18460519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small studies: strengths and limitations.
    Hackshaw A
    Eur Respir J; 2008 Nov; 32(5):1141-3. PubMed ID: 18978131
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.